• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by DaVita Inc.

    6/13/25 4:26:44 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care
    Get the next $DVA alert in real time by email
    11-K 1 a401k202411-k.htm 11-K Document

    UNITED STATES
     
    SECURITIES AND EXCHANGE COMMISSION


     
    Washington, D.C. 20549


     
    FORM 11-K



    [X]ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended December 31, 2024

    OR

    [_]TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the transition period from ___________ to _____________

    Commission file number 1-14106


    A.
    Full title of the plan and the address of the plan, if different from that of the issuer named below:

    DaVita Retirement Savings Plan

    B.
    Name of issuer of the securities held pursuant to the Plan and the address of its principal executive office:

    DaVita Inc.
    2000 16th Street
    Denver, Colorado 80202
















    DAVITA RETIREMENT SAVINGS PLAN
    Table of Contents
     
    Page
    Report of Independent Registered Public Accounting Firm
    1
    Financial Statements:
    Statements of Net Assets Available for Benefits
    2
    Statement of Changes in Net Assets Available for Benefits
    3
    Notes to Financial Statements
    4
    Supplemental Schedules:
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year)
    11
    Exhibit Index
    12
    Signature
    13





    Report of Independent Registered Public Accounting Firm


    To the Plan Administrator and Plan Participants of
    DaVita Retirement Savings Plan

    Opinion on the Financial Statements

    We have audited the accompanying statement of net assets available for benefits of the DaVita Retirement Savings Plan (the “Plan”) as of December 31, 2024 and 2023, the related statement of changes in net assets available for benefits for the year ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2024 and 2023, and the changes in net assets available for benefits for the year ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America.

    Basis for Opinion

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

    Opinion on the Supplementary Information

    The supplementary information included in Schedule H, line 4(i) – Schedule of Assets (Held at End of Year) as of December 31, 2024 has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplementary information is the responsibility of the Plan's management. Our audit procedures included determining whether the supplementary information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplementary information. In forming our opinion on the supplementary information in the accompanying schedule, we evaluated whether the supplementary information, including its form and content, is presented in conformity with Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplementary information in the accompanying schedule is fairly stated, in all material respects, in relation to the financial statements as a whole.

    /s/ Moss Adams LLP

    Everett, Washington
    June 13, 2025

    We have served as the Plan’s auditor since 2022.


    1


    DAVITA RETIREMENT SAVINGS PLAN
    Statements of Net Assets Available for Benefits
    December 31, 2024 and 2023
    (dollars in thousands)
     
    20242023
    Assets:
    Cash and cash equivalents $153 $268 
    Investments at fair value3,612,9853,131,239 
    Receivables:
    Notes receivable from participants133,073122,062 
    Employer contributions81,03875,590 
    Participant contributions910,502 
    Net assets available for benefits$3,827,258 $3,339,661 
    See accompanying notes to financial statements.


    2


    DAVITA RETIREMENT SAVINGS PLAN
    Statement of Changes in Net Assets Available for Benefits
    Year Ended December 31, 2024
    (dollars in thousands)
     
    2024
    Additions
    Investment income:
    Interest on investments$3,503 
    Dividends5,319 
    Net appreciation in fair value of investments420,380 
    Total investment income429,202 
    Participant notes receivable interest9,514 
    Contributions:
    Employer79,919 
    Participant316,788 
    Rollovers18,582 
    Total additions854,005 
    Deductions
    Benefit payments 358,713 
    Administration expenses 7,695 
    Total deductions366,408 
    Net increase in net assets available for benefits487,597 
    Net assets available for benefits at beginning of year 3,339,661 
    Net assets available for benefits at end of year $3,827,258 
    See accompanying notes to financial statements.


    3


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    (1)    Description of Plan
    The following description of the DaVita Retirement Savings Plan (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions. All capitalized terms used herein that are not defined, shall have the meanings given to them in the Plan.
    (a) General
    The Plan was established as a defined contribution plan for the benefit of employees of DaVita Inc. and its subsidiaries (the Company). Employees become eligible to participate immediately following the date of hire and attaining the age of 18 (however, a Participant must wait until the first of the month after attaining age 18 and completing 12 months of service before being eligible for the discretionary matching contribution). The Plan does not cover certain classes of individuals such as leased employees, independent contractors, nonresident aliens, residents of the Commonwealth of Puerto Rico, employees covered under a collective bargaining agreement or interns. The Plan is intended to qualify under Section 401(a) of the Internal Revenue Code of 1986, as amended (the Code), and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA).
    (b) Auto Enrollment
    All new employees of the Company, except employees from plans transferred into the Plan, are automatically enrolled in the Plan at a pre-tax deferral rate of six percent of Compensation upon meeting the eligibility requirements as described above.
    (c) Automatic Increase Contributions
    Participants who are deferring at least one percent but no more than nine percent of Compensation per pay period will have their deferral rate increased annually by one percent each January 1st until their deferral rate reaches 10%. All eligible Participants receive a notice of the right to opt out of the escalation of Automatic Contributions before such increased contributions are made. If the Participant does not make an affirmative election on or before the deadline, the Participant’s deferral rate in effect as of December 31 of the prior Plan Year will be increased as described above.
    (d) Contributions
    Participants may elect to contribute a minimum of one percent and maximum of 75% of their Compensation, subject to the legal limit allowed by the Code, into any of the investment options offered by the Plan. Participants may elect to contribute Compensation on a pre-tax basis, an after-tax (Roth) basis or a combination of both. Participants may change their election prospectively at any time.
    The Company has elected to make a discretionary matching contribution to the Plan for each eligible Participant in an amount equal to 50% of the Participant’s contributions, up to six percent of Compensation per each pay period. However, if the Participant had a minimum base salary of $120 and was in a position of director or above as of December 31 of the prior Plan Year, the maximum match in the current Plan Year for that Participant is $3.6. The matching contribution is calculated on a payroll by payroll basis, funded annually the following January and is only allocated to Participants who are employed on the last day of the Plan Year (unless the Participant died, became Totally and Permanently Disabled, or terminated on or after Normal Retirement Age). The Company’s discretionary matching contributions are invested in accordance with the Participant’s investment elections for Participant contributions.
    Participants may direct their investments into the DaVita Stock Fund, certain collective investment trust (CIT) and common commingled trust (CCT) funds and certain registered investment company funds as allowed under the Plan. The contributions of Participants who do not make elected investment options are automatically

    4


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    invested into various JPMorgan SmartRetirement Passive Blend funds, depending upon the age of the Participants. Participants cannot direct more than 20% of their contributions into the DaVita Stock Fund.
    Participants may elect to change their contribution percentage at any time and may change their investment elections or transfer amounts between funds daily, subject to applicable restrictions set forth in the insider trading policy of the Company if such elections or transfers involve the DaVita Stock Fund. Participants who have attained the age of 50 before the close of the Plan Year are also eligible to make catch-up contributions in accordance with, and subject to, the legal limitations of the Code.
    The Company may not elect to make discretionary contributions, except as part of the employer matching contributions discussed above.
    Participants may transfer rollover contributions from other qualified plans into their Plan account subject to provisions under the Plan. Rollovers must be made in cash within the time limit specified by the Code.
    (e) Participant Accounts
    The Plan recordkeeper maintains an account for each Participant’s contributions, allocations of Company contributions, if any, rollover contributions, investment earnings and losses and Plan expenses. Investment earnings and losses and Plan expenses are allocated to each account in the proportion that the account bears to the total of all Participants’ accounts. Participants’ accounts are valued on a daily basis based on the quoted market prices as reported by the investment funds, or the quoted market prices of the underlying securities.
    (f) Vesting
    Participants in the Plan will always be 100% vested in their section 401(k) contributions, and their rollover contributions and earnings thereon. Participants in the Plan prior to January 1, 2018 are 100% vested in employer matching contributions immediately, while Participants joining the Plan on or after January 1, 2018 vest in employer matching contributions 25% per year over a four year period. Employees become fully vested upon death, Total and Permanent Disability or Normal Retirement Age.
    (g) Benefit Payments
    Distributions from the Plan will be paid in the form of cash or if a Participant’s vested balance includes the DaVita Stock Fund, they may elect to receive a distribution of those shares. Participants may receive distributions either upon termination of service, by obtaining age 59½, by requesting a qualified birth or adoption distribution, by incurring a financial hardship, or upon termination of the Plan. Rollover and after‑tax contributions may be withdrawn at any time. Employee deferral contributions may not be distributed unless the Participant attains age 59½, incurs a financial hardship, requests a qualified birth or adoption distribution, or terminates service, or upon termination of the Plan. However, unless the Participant elects otherwise, distributions in cash will begin no later than sixty days after the close of the Plan Year, in which the latest following event occurs: Normal Retirement Age; ten years of participation in the Plan; or termination of service. Distributions are also required to begin by April of the calendar year following the calendar year in which the Participant attains age 73, or 72 if the Participant attained the age of 72 before January 1, 2023. The benefit to which a Participant is entitled is the benefit that can be provided from the Participant’s Vested Account.
    Terminated Participants with Vested Account balances greater than $1 and less than $7 will have their account transferred to another qualified account unless they elect to have a rollover or lump sum payment. For termination of service with Vested Account benefits of $1 or less, a Participant may automatically receive the Vested Account interest in his or her account in a lump sum distribution unless a rollover is elected.
    Distributions for financial hardship can only be made both on account of an immediate and heavy financial need, and be necessary to satisfy that need. Only the Participant’s tax deferred contributions, Roth contributions,

    5


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    vested matching contributions and rollover contributions may be distributed for financial hardship. Earnings and Company discretionary contributions are not eligible for financial hardship distributions.
    In the event of the death of a Participant, the Participant’s Vested Account balance will be distributed to the Participant’s beneficiary as soon as reasonably practicable.
    If a Participant ceases to make loan repayments and the Plan Administrator deems the Participant loan to be in default, the Participant loan balance is reduced, and a benefit payment is recorded (deemed distribution).
    (h) Forfeitures
    At December 31, 2024 and 2023, forfeited non-vested accounts totaled $1,577 and $1,083, respectively. These accounts may be used to reduce future employer contributions or pay Plan expenses. During 2024, forfeitures of $1,120 were used to reduce employer contributions.
    (i) Notes Receivable From Participants
    The Plan permits Participants to borrow a minimum of $1 from their Participant accounts. Subject to the Code and Plan limits, such notes receivable cannot exceed the lesser of 50% of the value of the Participant’s Vested Account, or $50, reduced for any prior notes receivable outstanding.
    The notes receivable must be repaid generally within five years or within 10 years when the proceeds are used to purchase a principal residence of the Participant and bears a fixed interest rate at prime as stated in the Wall Street Journal on the last day of the month preceding the month in which the note receivable is made plus one percent. The interest rates on outstanding notes receivable ranged from 4.25% to 9.50% at December 31, 2024, with maturities through October 2034. Notes receivable are secured by the Participant's Vested Account.
    (j) Plan Termination
    Although it has not expressed the intent to do so, the Company has the right to terminate the Plan at any time subject to the provisions under ERISA. If the Plan is terminated, each Participant’s account balance will be fully vested and distributed in a timely manner.
    (2)    Summary of Significant Accounting Policies
    (a) Basis of Accounting
    The accompanying financial statements are prepared on the accrual basis of accounting, in accordance with accounting principles generally accepted in the United States of America.
    Plan Management evaluated for disclosure or recognition any subsequent events through June 13, 2025, the issuance date of the financial statements.
    (b) Income Recognition and Net Investment Income
    Purchases and sales of securities are recorded on a trade‑date basis. Interest income is accrued when earned. Dividends are recorded on the ex‑dividend date. Net appreciation in fair value of investments includes the Plan's realized gains and losses on investments bought and sold during the year as well as the appreciation or depreciation on investments held at year-end.
    (c) Investments
    The Plan’s investments are stated at fair value. Investments in shares of registered investment company funds are reported at fair value based on quoted market prices (the net asset values) as reported by each investment fund. The DaVita Stock Fund is valued at fair value based on the year‑end closing price of the underlying stock, as reported on the New York Stock Exchange, plus uninvested cash position.

    6


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    The T. Rowe Price Stable Value Common Trust Fund (Stable Value Fund) is a CCT fund investing primarily in guaranteed investment contracts (GICs), bank investment contracts, synthetic GICs and/or separate account contracts. The target retirement date funds and certain other funds are invested in CCTs and CITs, respectively. These CCT and CIT funds are priced daily using the net asset values as published by each investment fund. Investments in CCT and CIT funds are recorded at fair value using the price at which Participants are able to transact under the terms of the Plan as measured and available for redemption on a daily basis by the CCT and CIT fund managers.
    (d) Risks and Uncertainties
    The Plan provides for various investment fund options, which in turn invest in a combination of stocks, bonds and other investment securities. Investment securities, in general, are exposed to various risks, such as interest rate, credit and overall market volatility risks. Due to the high level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and such changes could materially affect the amounts reported in the statements of net assets available for benefits.
    (e) Receivables – Notes Receivable From Participants
    Notes receivable from Participants are measured at their unpaid outstanding principal balance plus any accrued but unpaid interest. Interest income is recorded on the accrual basis. Delinquent loans are recorded as distributions based on the terms of the Plan document.
    (f) Receivables – Participant Contributions
    Receivables from Participant contributions are stated at net realizable value, and represent deferrals of employees’ Compensation that have not yet been contributed to the Plan.
    (g) Receivables – Employer Contributions
    Receivables from employer contributions are stated at net realizable value, and represent employer matching contributions that have not yet been contributed to the Plan.
    (h) Benefit Payments
    Benefits are recorded when paid.
    (i) Administrative Expenses and Investment Management Fees
    All operational administrative costs of the Plan are deducted from Participants’ account balances except certain transaction costs associated with the recordkeeping of the DaVita Stock Fund, which are borne by the Company. Administrative costs include trustee fees, recordkeeping, Participant reporting costs, brokerage fees, Participant notes receivable costs, accounting and legal fees, commissions and transactions charges. Investment management fees are paid by each respective investment fund and are deducted in arriving at each fund’s overall net asset value. Fees deducted from Participant accounts are held within the Plan and invested in the Vanguard Federal Money Market Fund as a nonparticipant-directed investment until used to pay Plan administrative expenses.
    (j) Use of Estimates
    The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires Plan Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

    7


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    (3)    Party‑in‑Interest Transactions
    Voya Financial is the Trustee and recordkeeper for the Plan. Each fund within the Plan has its own investment manager. The transfer of assets, as well as the recordkeeping functions of the Plan qualify as party-in-interest transactions. Additionally, the Company provided personnel and administrative functions for the Plan at no charge to the Plan. The Plan also holds shares of DaVita Inc. Common Stock, which qualifies as party-in-interest transactions under the provisions of ERISA. During the year ended December 31, 2024, the Plan made purchases of approximately $6,119 and sales of approximately $8,881 of DaVita Inc. Common Stock. State Street Corporation is the custodian of the shares held in the DaVita Stock Fund.
    (4)    Tax Status
    The Plan is maintained on the Voya Retirement Insurance and Annuity Company Non-Standardized Defined Contribution Pre-Approved Plan which includes a Base Plan Document and Adoption Agreement, for which Voya received a favorable opinion letter, dated June 30, 2020, from the Internal Revenue Service (IRS). The Plan was restated on the Pre-Approved Plan document, effective January 1, 2022, and has been amended subsequently. Plan Management believes the Plan is designed and is currently being operated in compliance with the applicable requirements of Section 401(a) of the Code, and as a result, is exempt from federal income taxes under Section 501(a) of the Code.
    U.S. generally accepted accounting principles require Plan Management to evaluate tax positions taken by the Plan and recognize a tax liability (or asset) if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the IRS. The Plan Administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2024, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions. The Plan Administrator believes it is no longer subject to income tax examinations for years prior to 2021.
    (6)    Nonparticipant-directed investments
    Information about the net assets and the significant components of the changes in net assets for the year ended December 31, 2024 relating to the nonparticipant-directed investments is as follows:
    Vanguard Federal Money Market Fund
    2024
    Net assets, beginning of year$4,833 
    Change in net assets
    Dividends257 
    Transfers in — administration fees, forfeitures and other
    2,160 
    Disbursements — administration fees, forfeitures and other
    (1,576)
    Net assets, end of year$5,674 
    (7)    Fair Value Measurements
    The Plan measures the fair value of its assets based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets under a fair value hierarchy. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to quoted prices in active markets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

    8


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    The following table summarizes the Plan’s assets measured at fair value on a recurring basis as of December 31, 2024:
    TotalQuoted prices in
    active markets for
    identical assets
    (Level 1)
    Significant other
    observable inputs
    (Level 2)
    Significant
    unobservable
    inputs
    (Level 3)
    Investments in Registered Investment
     Company Funds
    $102,239 $102,239 $— $— 
    Investments in CCT and CIT Funds3,455,929 3,338,296 117,633 — 
    DaVita Stock Fund54,817 54,817 — — 
    Total assets in fair value hierarchy$3,612,985 $3,495,352 $117,633 $— 
    The following table summarizes the Plan’s assets measured at fair value on a recurring basis as of December 31, 2023:
    TotalQuoted prices in
    active markets for
    identical assets
    (Level 1)
    Significant other
    observable inputs
    (Level 2)
    Significant
    unobservable
    inputs
    (Level 3)
    Investments in Registered Investment
     Company Funds
    $53,780 $53,780 $— $— 
    Investments in CCT and CIT Funds3,037,078 2,913,562 123,516 — 
    DaVita Stock Fund40,381 40,381 — — 
    Total assets in fair value hierarchy$3,131,239 $3,007,723 $123,516 $— 
    The investments in registered investment company funds are recorded at fair value based upon quoted market prices as reported by each investment fund.
    Investments in CCT and CIT funds are recorded at fair value using the price at which Participants are able to transact under the terms of the Plan as measured and available for redemption on a daily basis by the CCT and CIT fund managers. For the Stable Value Fund, the Plan is required to provide 12 months' advance written notice to the trustee prior to redemption of trust units upon withdrawal from the fund. There are no restrictions related to the redemption notice period and there were no unfunded commitments at December 31, 2024. The Stable Value Fund is considered within Level 2 of the fair value hierarchy above. See (2)(c) under Summary of Significant Accounting Policies for further discussions.
    The DaVita Stock Fund is recorded at fair value based upon quoted market prices as reported by the New York Stock Exchange. See (2)(c) under Summary of Significant Accounting Policies for further discussion.
    The methods used for determining fair value may not be reflective of the actual values that will be received upon settlement of the securities due to fluctuations in the market. However, Plan Management believes the methods used to measure the fair value of its assets are appropriate and are based upon relevant market factors, such as quoted prices or observable market inputs. The use of different methods or assumptions could result in a different fair value measurement at the reporting date.

    9


    DAVITA RETIREMENT SAVINGS PLAN
    Notes to the Financial Statements
    December 31, 2024 and 2023
    (dollars in thousands)

    (8)    Reconciliation of Plan Financial Statements to the Form 5500
    The following is a reconciliation of the Plan financial statements to the Form 5500 for the years ended December 31, 2024 and 2023:
    20242023
    Net assets available for benefits:
    Net assets available for benefits per Plan financial statements $3,827,258 $3,339,661 
    Deemed distributions(13,132)(13,441)
    Net assets available for benefits per Form 5500 $3,814,126 $3,326,220 
    2024
    Net income:
    Net increase in net assets available for benefits per Plan financial statements$487,597 
    Deemed distributions309 
    Net Income per Form 5500 $487,906 

    (9)    Contingencies
    On March 23, 2022 a putative class action (Teodosio et al. v. DaVita Inc. et al.) was filed in the U.S. District Court for the District of Colorado against the DaVita Inc., DaVita Inc.’s Board of Directors, the Plan Administrative Committee for the Company's 401(k) plan, and 30 “John Does.” The complaint alleged that the defendants breached their fiduciary duties under ERISA by charging excessive recordkeeping and administrative costs to Plan Participants. In January 2024, the parties agreed to settle the matter for an immaterial amount. The Court granted final approval of the settlement in December 2024.

    10


    DAVITA RETIREMENT SAVINGS PLAN
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year)
    December 31, 2024
    (dollars in thousands)
    Identity of issuer, borrower, lessor, or similar partyDescription of investmentCurrent value
    Common Commingled Trust and Collective Investment Trust Funds:
    T. Rowe PriceT. Rowe Price Stable Value Common Trust Fund - Class Q$117,633 
    T. Rowe PriceT. Rowe Price Large-Cap Growth Trust (Class B)130,393 
    JPMCBJPMCB SmartRetirement Passive Blend Income Fund CF-B33,043 
    JPMCBJPMCB SmartRetirement Passive Blend 2020 Fund CF-B85,792 
    JPMCBJPMCB SmartRetirement Passive Blend 2025 Fund CF-B170,628 
    JPMCBJPMCB SmartRetirement Passive Blend 2030 Fund CF-B253,195 
    JPMCBJPMCB SmartRetirement Passive Blend 2035 Fund CF-B349,637 
    JPMCBJPMCB SmartRetirement Passive Blend 2040 Fund CF-B318,267 
    JPMCBJPMCB SmartRetirement Passive Blend 2045 Fund CF-B280,596 
    JPMCBJPMCB SmartRetirement Passive Blend 2050 Fund CF-B270,971 
    JPMCBJPMCB SmartRetirement Passive Blend 2055 Fund CF-B214,842 
    JPMCBJPMCB SmartRetirement Passive Blend 2060 Fund CF-B83,964 
    JPMCBJPMCB SmartRetirement Passive Blend 2065 Fund - C Class18,973 
    PrudentialJennison Small/Mid Cap Fund23,380 
    VanguardVanguard Total Bond Market Index Fund 232,039 
    VanguardVanguard Institutional Index Fund457,027 
    VanguardVanguard Extended Market Index Institutional Fund179,985 
    VanguardVanguard Total International Stock Index Fund235,564 
    Registered Investment Company Funds:
    **VanguardSTIF Holding Fund-Vanguard Federal Money Market Fund5,674 
    Dodge and CoxDodge & Cox Stock Fund37,316 
    American FundsAmerican Funds EuroPacific Growth Fund15,110 
    BairdBaird Core Plus Bond Fund 44,139 
    Common Stock:
    *DaVita Inc.DaVita Stock Fund54,817 
    *Participant loans4.25% – 9.50% maturing through October 2034133,073 
    Total Investments $3,746,058 
    * Represents a party-in-interest.
    ** Nonparticipant-directed investments. Costs of the nonparticipant directed investments approximate current value at December 31, 2024.
    See accompanying report of independent registered public accounting firm.

    11



    EXHIBIT INDEX
    Exhibit No.Description
    23.1
    Consent of Moss Adams LLP Independent Registered Public Accounting Firm.

    12


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly
    authorized.

     DAVITA RETIREMENT SAVINGS PLAN
     
     BY: /s/ Nihar Shah
       Nihar Shah
       Designated Representative of the Plan
    Administrator

    Date: June 13, 2025
    13
    Get the next $DVA alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $DVA

    DatePrice TargetRatingAnalyst
    3/6/2024$133.00Equal Weight
    Barclays
    8/7/2023$100.00 → $142.00Neutral → Buy
    UBS
    11/1/2022$97.00 → $72.00Buy → Hold
    Deutsche Bank
    10/31/2022$117.00 → $74.00Buy → Neutral
    UBS
    8/19/2022$106.00 → $117.00Buy
    UBS
    6/21/2022$110.00 → $90.00Underperform
    BofA Securities
    1/5/2022$114.00 → $125.00Hold
    Truist Securities
    10/29/2021$113.00 → $111.00Sector Perform
    RBC Capital
    More analyst ratings

    $DVA
    SEC Filings

    See more
    • SEC Form 11-K filed by DaVita Inc.

      11-K - DAVITA INC. (0000927066) (Filer)

      6/13/25 4:26:44 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - DAVITA INC. (0000927066) (Filer)

      6/9/25 4:31:13 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - DAVITA INC. (0000927066) (Filer)

      5/23/25 4:28:44 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

      DENVER, May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek, chief transformation officer for DaVita. "As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices (KCC) Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emph

      5/30/25 2:35:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

      Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER, May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE:DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental, Social and Governance (ESG) goals set to be achieved this year. Milestones and achievements reflect calendar year 2024. In 2021, DaVita announced broadened ESG goals and has since reported progress against its five strategic focus areas: Patient Care, Teammate Engagement, Environmental Stewardship, Healthy Communities and Leading with Integrity and Accountability. "This year, we're celebrating 25 years

      5/20/25 9:05:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. 1st Quarter 2025 Results

      DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders." Financial and operating highlights for the quarter ended March 31, 2025: Consolidated revenues were $3.224 billion.Operating income was $439 million.Diluted earnings per share was $2.00.Operating cash flow was $180 million and free cash flow was $(45) million.Repurchased 3.7 milli

      5/12/25 4:05:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on DaVita with a new price target

      Barclays initiated coverage of DaVita with a rating of Equal Weight and set a new price target of $133.00

      3/6/24 8:09:27 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita upgraded by UBS with a new price target

      UBS upgraded DaVita from Neutral to Buy and set a new price target of $142.00 from $100.00 previously

      8/7/23 7:20:56 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded DaVita from Buy to Hold and set a new price target of $72.00 from $97.00 previously

      11/1/22 9:18:39 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Moore Gregory J. was granted 348 shares, increasing direct ownership by 6% to 6,451 units (SEC Form 4)

      4 - DAVITA INC. (0000927066) (Issuer)

      5/16/25 9:15:16 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • Director Berg Charles was granted 348 shares, increasing direct ownership by 2% to 19,982 units (SEC Form 4)

      4 - DAVITA INC. (0000927066) (Issuer)

      5/16/25 9:15:04 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • Director Yale Phyllis R was granted 348 shares, increasing direct ownership by 3% to 13,201 units (SEC Form 4)

      4 - DAVITA INC. (0000927066) (Issuer)

      5/16/25 9:14:55 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Financials

    Live finance-specific insights

    See more
    • DaVita Inc. 1st Quarter 2025 Results

      DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders." Financial and operating highlights for the quarter ended March 31, 2025: Consolidated revenues were $3.224 billion.Operating income was $439 million.Diluted earnings per share was $2.00.Operating cash flow was $180 million and free cash flow was $(45) million.Repurchased 3.7 milli

      5/12/25 4:05:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

      DENVER, April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:  Monday, May 12, 2025Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042 When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the

      4/30/25 11:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. 4th Quarter 2024 Results

      DENVER, Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said Javier Rodriquez, CEO of DaVita Inc. "As we embark on 2025, when we will be celebrating the 25th anniversary of DaVita, we look forward to continuing our efforts to improve clinical outcomes, enhance quality of life for our patients and teammates, and be a force for positive change in the healthcare system." Financial and operating highlights for the quarter and year ended Decembe

      2/13/25 4:05:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Leadership Updates

    Live Leadership Updates

    See more
    • DaVita Appoints Jessica Hergenreter as Chief People Officer

      DENVER, Oct. 17, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced Jessica (Jess) Hergenreter as its new chief people officer (CPO). In this position, Hergenreter will oversee DaVita's People Services team, leading initiatives to engage and uplift DaVita's more than 70,000 teammates (employees) worldwide. Earlier this year, DaVita was named as a Top Workplace by USA Today and one of America's Most Loved Companies by Newsweek. "Our incredible teammates are the difference makers for the care we provide to patients," said Javier Rodriguez, C

      10/17/24 1:00:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

      DENVER, Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer. This appointment builds on Maughan's 18-year tenure at DaVita in a range of leadership roles. After a celebrated 11-year tenure as chief operating officer, Mike Staffieri will step into the role of chief operating officer emeritus. Both appointments are effective September 15, 2024. "It's an exciting time for DaVita! Dave's extensive experience in operations leadership coupled with his deep knowledge of DaVita's business positions him well to build upon our incredible foundation of operational excellence and lead our on

      9/13/24 8:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Appoints New Chief Information Officer

      Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita  DENVER, May 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that Madhu Narasimhan will assume the role of chief information officer (CIO), effective June 3, 2024. In this leadership position, Narasimhan will be responsible for accelerating the implementation of DaVita's industry-leading health technology platforms. She will oversee DaVita's technology innovation strategy, including enterprise priorities like Center Without Walls™ (CWOW®),

      5/13/24 9:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

      SC 13G/A - DAVITA INC. (0000927066) (Subject)

      2/13/24 5:02:42 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

      SC 13G/A - DAVITA INC. (0000927066) (Subject)

      2/9/22 3:43:35 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by DaVita Inc. (Amendment)

      SC 13D/A - DAVITA INC. (0000927066) (Subject)

      8/4/21 4:02:59 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care